Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. NJ BioHistory (TM)
Career
Job Search Post a Job Destination NJ
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: The Norway Foundation
Facilities
 
Events
 

Earn a UW master’s or certificate in medical engineering or pharmaceutical bioengineering.

ORCA Annual Meeting & Social: Sept. 22 - Save the Date! (PDF 86 kb)


BioHistory Moment: FDA requested help in removing a hazardous product, "X-33 Water Repellent," from the market

German chemist Felix Hoffmann synthesized aspirin and heroin

On August 30, 1964, the FDA asked state and local health and safety officials for help in removing "X-33 Water Repellent" from the market. The extremely flammable product had caused three deaths and more than 30 injuries through flash explosions, in many cases while it was being used in home basements to waterproof masonry.

Federal oversight of consumer products such as X-33 and many other items used in the home was transferred to the newly created Consumer Product Safety Commission in 1973. One class of consumer products still regulated by the FDA is radiation-emitting products.

More...

Learn about Seattle's Life Science Incubator Facility

PNDRI Building, First Hill, Seattle, WA. Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington, the Fred Hutchinson Cancer Research Center, and more.

Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in New Jersey, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • Allergan resolves investigation of past sales and marketing practices related to BOTOX(R)  Allergan announced a resolution with the U.S. Department of Justice regarding Allergan's past U.S. sales and marketing practices relating to therapeutic uses of BOTOX. Allergan pled guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and will pay $375 million.
    Allergan, Inc.   September 01, 2010  


  • Implant Sciences appoints Bruce Bower as senior vice president  Implant Sciences announced the appointment of Bruce Bower into the newly created position of Senior Vice President. In this position, Mr. Bower will lead Implant Sciences' marketing and sales efforts.
    Implant Sciences Corporation   September 01, 2010  


  • Merck and Cardiome annoumnce BRINAVESS for infusion approved in the European Union  Merck and Cardiome Pharma Corp. announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the rapid conversion of recent onset atrial fibrillation.
    Merck & Co., Inc.  September 01, 2010  


  • BARDA funds development of new way to treat illness from acute radiation  The HHS Biomedical Advanced Research and Development Authority awarded a $153 million contract to Cellerant Therapeutics of San Carlos, Calif., to continue developing a new way to treat an illness caused by exposure to high levels of ionizing radiation which can damage the body’s cells.
    U.S. Health & Human Services  September 01, 2010  


  • U.S. Court of Appeals upholds validity of Lilly's Evista patents through March of 2014  Eli Lilly and Company announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista are valid in the U.S. through March of 2014.
    Eli Lilly and Company  September 01, 2010  


More... | Submit News Release | Advertising...

UW Surplus

New Job Postings...

Free Job Posting Trial Offer
  • Head of Medical Affairs Operations  Seattle Genetics, Inc. (WA)
  • Molecular & FISH Technologist CellNetix Pathology and Laboratories  (WA)
  • Animal Technician I Benaroya Research Institute (WA)
  • Research Technician I/II Benaroya Research Institute (WA)
  • Postdoctoral Research Associate Benaroya Research Institute (WA)
More... | Job Advertising... | About Job Postings...
EquipNet

New Facilities Available...

ATC clean room constructors...validation guaranteed!

  • 890 Embarcadero Road Property -- West Sacramento, CA
  • Icogenex Biotech Incubator -- Seattle, WA
  • Biotech and Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
Gilead - Careers for Life

Upcoming Events...

  • 09/07/2010: Bio Tuesday at EpiVax, Inc.
  • 09/08/2010: 2010 We Mean Business Expo
  • 09/09/2010: Drug Development Boot Camp
  • 09/12/2010: 2010 Agricultural Biotechnology International Conference
  • 09/13/2010: The Future of Bio-Based Chemicals – Inception to Marketplace
More... | Submit Event | Event Advertising...
Novo Nordisk Banner Ad

Learn About New Jersey's BioHistory

Learn About New Jersey's BioHistory Why is there a life science industry in New Jersey? Is the industry growing? What do other states have?

Through New Jersey BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in New Jersey.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


August: National Immunization Awareness Month

National Immunization Awareness Month

The goal of National Immunization Awareness Month (NIAM) is to increase awareness about immunizations across the life span, from infants to the elderly.

Immunization is one of the most significant public health achievements of the 20th century. Vaccines have eradicated smallpox, eliminated wild poliovirus in the U.S. and significantly reduced the number of cases of measles, diphtheria, rubella, pertussis and other diseases. But despite these efforts, people in the U.S. still die from these and other vaccine-preventable diseases.

More...


BioFact

(1963) - Congress establishes the Immunization Grant Program; polio incidence plummets to only 396 reported cases in the United States.


It's a Small World

  Salmonella Bacteria Salmonella Bacteria  

Science Quote

" "It is unworthy of excellent men to lose hours like slaves in the labor of calculation which could be relegated to anyone else if machines were used.""

-  Gottfried Wilhelm von Leibnitz -German philosopher and mathematician
 (1646-1716)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

NewJerseyLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of New Jersey.